May 19, 2023
A jury found the CEO of a Miami clinical drug trial company and an employee not guilty on Thursday of all charges connected to an alleged scheme to falsify research and defraud drugmakers, although it did convict a third defendant of making false statements.
November 21, 2022
A case against the CEO of a Miami clinical trial company indicted in a scheme to falsify research and defraud drugmakers will move forward after a federal judge rejected her claim that the government's delay in filing charges prejudiced her ability to mount a defense.